Progestins, breast cancer, and the limitations of epidemiology.
Grimes
D A
DA
D000814:Aniline Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000139:chemically induced / Q000453:epidemiology*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D011372:Progestins
D000814:Aniline Compounds; D003692:Delayed-Action Preparations; D011372:Progestins; C050795:N,N-dimethyl-4-anisidine